OncoMatch/Clinical Trials/NCT06905132
Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma
Is NCT06905132 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies non-drug interventions for soft tissue sarcoma.
The purpose of this research study is to preserve healthy tissue around the cancer on the arm(s) and/or leg(s) using Hypofractionated radiotherapy, while treating the cancer and preventing it from spreading to other areas of the body.
Check if I qualifyExtracted eligibility criteria
Cancer type
Sarcoma
Disease stage
Excluded: Stage DISTANT METASTATIC DISEASE
Distant metastatic disease [excluded]
Performance status
ECOG 0–3(Limited self-care)
Prior therapy
Cannot have received: radiation therapy
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- Medical University of South Carolina · Charleston, South Carolina
Showing up to 5 US sites. See all sites on ClinicalTrials.gov →
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify